Current role
Biotechnology · Healthcare
Board Member
2023-06-21–present
Stephen S. Yoder
Board Member
Palvella Therapeutics, Inc. (PVLA)Equibles does not estimate personal net worth.
About Stephen S. Yoder
Stephen S. Yoder is recorded as Board Member at Palvella Therapeutics, Inc. (PVLA) since June 21, 2023. Palvella Therapeutics, Inc. reported in an 8-K filed June 26, 2023 that Stephen S. Yoder was appointed Class III director, effective June 21, 2023. The proxy statement of Palvella Therapeutics, Inc. reports total compensation of $1,358,952 for Stephen S. Yoder in fiscal 2023, including a base salary of $584,595. Disclosed compensation is on record for 6 fiscal years. Palvella Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palvella Therapeutics, Inc. includes Wesley H. Kaupinen (CEO and Board Member), George M. Jenkins (Chairman and Board Member), James Geraghty (Chairman) and 7 others.
“elected each of Stephen S. Yoder, Michael Richman, and Matthew L. Sherman, M.D. to the Company's Board of Directors as Class III directors, each to serve for a three-year term expiring at the 2026 annual meeting of stockholders”
Affiliation history
-
Current
2023-06-21–present
-
Start not stated–2024-11-06
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Palvella Therapeutics, Inc.
- Wesley H. Kaupinen CEO, Board Member
- George M. Jenkins Chairman, Board Member
- James Geraghty Chairman
- Matthew E. Korenberg CFO
- Matthew Korenberg CFO
- Kathleen Goin COO
- Jeffrey Martini CTO
- Jeffrey Martini, Ph.D. CTO
- Christopher Kiritsy Board Member
- Elaine J. Heron Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $584,595 | $1,358,952 |
| 2022 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $564,826 | $2,062,843 |
| 2021 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $548,375 | $1,692,917 |
| 2020 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $535,000 | $1,538,829 |
| 2019 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $515,000 | $1,593,598 |
| 2018 | Palvella Therapeutics, Inc. (PVLA) | Chief Executive Officer | $500,000 | $2,621,008 |